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Abstract
Objective—To analyze differences in carpal tunnel syndrome (CTS) prevalence using a 
combination of electrodiagnostic studies (EDSs) and symptoms using EDS criteria varied across a 
range of cutpoints and compared with symptoms in both ≥1 and ≥2 median nerve–served digits.
Design—Pooled data from 5 prospective cohorts.
Setting—Hand-intensive industrial settings, including manufacturing, assembly, production, 
service, construction, and health care.
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Participants—Employed, working-age participants who are able to provide consent and undergo 
EDS testing (N=3130).
Interventions—None.
Main Outcome Measures—CTS prevalence was estimated while varying the thresholds for 
median sensory latency, median motor latency, and transcarpal delta latency difference. EDS 
criteria examined included the following: median sensory latency of 3.3 to 4.1 milliseconds, 
median motor latency of 4.1 to 4.9 milliseconds, and median-ulnar sensory difference of 0.4 to 1.2 
milliseconds. EDS criteria were combined with symptoms in ≥1 or ≥2 median nerve–served digits. 
EDS criteria from other published studies were applied to allow for comparison.
Results—CTS prevalence ranged from 6.3% to 11.7%. CTS prevalence estimates changed most 
per millisecond of sensory latency compared with motor latency or transcarpal delta. CTS 
prevalence decreased by 0.9% to 2.0% if the criteria required symptoms in 2 digits instead of 1.
Conclusions—There are meaningful differences in CTS prevalence when different EDS criteria 
are applied. The digital sensory latency criteria result in the largest variance in prevalence.
Keywords
Carpal tunnel syndrome; Diagnostic techniques and procedures; Electrodiagnosis; Prevalence; 
Rehabilitation; Standards
Carpal tunnel syndrome (CTS) is a common and costly musculoskeletal disorder with 
annual U.S. costs estimated at $2 billion.1 Prevalence has been estimated at 1.5% to 5.8% in 
the general population, with higher prevalence rates in specific sub-populations.2–7
The case definition of CTS used in epidemiologic research often includes documentation of 
dysesthesias in the median nerve distribution of the hand and electrodiagnostic study (EDS) 
results consistent with median nerve mononeuropathy at the wrist.8 Clinical studies often 
rely on similar criteria, but they may also use a more detailed medical history, presence of 
nocturnal symptoms, and additional diagnostic maneuvers. However, diagnostic maneuvers 
(eg, Phalen or Hoffman-Tinel test) contribute relatively little to the predictive value.9–12
Prior studies have used a variety of criteria for evaluating the slowing of median nerve 
conduction results consistent with CTS.13–24 Nerve conduction outcomes are a continuous 
measure reported as either latency (ms) or velocity (m/s). Therefore, when using nerve 
conduction outcomes to distinguish results that are consistent with CTS from those that are 
not, investigators must select a cutpoint or threshold at which to dichotomize the 
distributions. Such values have ranged from 3.4 to 4.0 milliseconds for median sensory 
nerve latencies, 4.0 to 4.6 milliseconds for median motor nerve latencies, and 0.3 to 1.0 
millisecond for the median-ulnar nerve sensory latency difference (transcarpal 
delta).2,21,25–33 There appears to be no consensus on optimal EDS criteria for CTS in either 
epidemiologic or clinical settings. Research is also relatively sparse regarding the impacts of 
varying EDS criteria on observed disease prevalence.17–19,31,34–38
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The purpose of this study was to evaluate the effect of a range of EDS criteria in 
combination with 2 symptom criteria on observed CTS prevalence in a large population of 
workers from a wide range of industries and across multiple regions of the United States.
Methods
Study design
Data from 5 prospective cohort studies that used comparable methods and have been 
previously described were pooled for the current analyses.37,39–43 In short, all studies were 
prospective cohort studies enrolling workers in a variety of industrial settings. The common 
objective of these studies was to quantify relationships between EDS factors and two case 
definitions of CTS. These analyses are of cross-sectional baseline symptoms data and 
dominant hand EDS measures in all participants, regardless of symptomology. All primary 
data were available and used; therefore, this is a pooled analysis of original data, not a meta-
analysis of published mean values. Institutional review boards approved each of the 5 
individual studies, and written consent was obtained from all study participants prior to their 
enrollment and participation.
Participants
Study participants were ≥18 years old, able to provide consent, and currently employed in a 
broad variety of industrial settings in which the enrolled workers performed a wide range of 
hand-intensive activities. Industrial settings included manufacturing, production, service, 
construction, and health care. Data collection for these studies’ baseline enrollments were 
conducted from 2001 to 2006. A total of 4321 subjects were enrolled.
All studies were approved by the appropriate institutional review board and were performed 
in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and 
all subsequent amendments. All participants provided informed consent prior to 
participation.
Baseline questionnaires collected information on demographics, medical history, 
psychosocial factors, work history, and musculoskeletal symptoms. EDSs of the median 
motor nerve and median sensory nerve and the ipsilateral ulnar sensory nerve across the 
wrist were collected in the dominant hand on all participants regardless of symptoms at the 
time of enrollment.
Participants were excluded from these analyses if they were missing baseline symptoms or 
had invalid EDS latency results (n=856, 19.4%).
Symptoms data collection
Most participants had symptoms recorded by digit in the first (thumb), second (index 
finger), third (middle finger), and fourth (ring finger) digits. Symptoms in the fifth digit 
were not used in these analyses. In 2 studies, a hand symptom diagram was used to collect 
symptom location and characteristics in all but the fourth digit (eg, tingling, numbness, 
pain).44 In the remaining 4 studies, symptoms were recorded during standard interviews 
conducted by a medical professional. For the purpose of the current analyses, 2 symptom 
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criteria were applied separately: tingling, numbness, burning, or pain in ≥1 median 
innervated digit (thumb, index, middle, ring), and these symptoms in ≥2 median innervated 
digits.
EDS measures
All study sites collected 3 measures often used to characterize median nerve function at the 
wrist: median sensory nerve latency, median motor nerve latency, and the difference 
between the median and ulnar nerve sensory latencies across the wrist (transcarpal delta). 
All sensory latencies were peak measures, and all motor latencies were onset measures. All 
EDSs were performed unilaterally on the dominant hands. Three study groups used 
conventional clinical electrophysiology/electromyography equipment (XLTEK NeuroMax 
1002,a Cadwell 6200A,b Teca Synergy N2c), and 2 studies used a portable nerve testing 
device (NC-statd). The NC-stat has preconfigured sensors on the electrodes to accommodate 
different hand dimensions. The specific model numbers used were NC-S51, NC-S52, and 
NC-S53 for small, medium, and large median motor and sensory latencies and NC-S61 and 
NC-S62 for right and left ulnar motor and sensory latencies, respectively. Each sensor has 
anatomic locations to facilitate ease of use, and strict cleaning procedure was followed per 
the manufacturer’s recommendations. The NC-stat has demonstrated agreement with 
conventional EDS devices for measures of median motor and sensory nerve latencies.45–50 
EDSs were performed according to standard electrodiagnostic testing protocols.14 Stratified 
analyses comparing distributions of symptoms and EDS criteria by study showed no 
statistically significant differences between electro-diagnostic testing devices across the 5 
studies; therefore, all data were pooled into a single dataset for analyses.
Most sensory latency values were measured at the standard distance of 14cm; however, 
some hands were too small. If not measured at 14cm, they were standardized to a 14-cm 
distance. No motor latencies were corrected. All median sensory measures were antidromic. 
Skin temperature was measured prior to testing, and hands were warmed to a minimum skin 
temperature of 30°C to 32°C by 4 of the 5 study groups included in the analyses. Regression 
analyses were used to adjust latency values to a standard temperature of 32°C as described 
in a prior publication.39 Nominal changes were observed when temperature correction was 
applied.
CTS case definitions
An analysis was conducted by calculating the prevalence of CTS over a range of EDS 
threshold (ie, cutoff) values in combination with each of the 2 symptom-based criteria: 
symptoms in ≥1 digits and symptoms in ≥2 digits. Only 1 of the 3 EDS measures was varied 
at the time, while the others were held constant at an a priori selected reference value. For 
example, median sensory and median motor latencies were held at 3.7 and 4.5 milliseconds, 
respectively, whereas the transcarpal delta varied from 0.4 to 1.2 milliseconds, in 0.1-
millisecond increments. Consequently, a set of 6 analyses were conducted (ie, 3 EDS criteria 
aXLTEK NeuroMax 1002; Natus Medical Incorporated, 5900 First Ave S, Seattle, WA 98108.
bCadwell 6200A; Cadwell Laboratories, Inc, 909 N Kellogg, Kennewick, WA 99336.
cTeca Synergy N2; Oxford Instruments, 12 Skyline Dr, Ste 230, Hawthorne, NY 10532-2133.
dNC-stat; NeuroMetrix, Inc, 62 4th Ave, Waltham, MA 02451.
Thiese et al. Page 4
Arch Phys Med Rehabil. Author manuscript; available in PMC 2015 February 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
by 2 symptom criteria). The reference values used for these calculations were 3.7 
milliseconds for median sensory latency, 4.5 milliseconds for median motor latency, and 0.8 
millisecond for transcarpal delta latency. These reference values were selected based on 
criteria commonly used in prior publications.
For the analyses, median sensory latency, median motor latency, and transcarpal delta 
latency thresholds were each varied separately in 0.1-millisecond intervals up to 0.4 
millisecond above and below the reference values, for a total of 9 threshold values each. For 
example, given the reference value of 3.7 milliseconds for the median sensory latency, the 
prevalence of CTS was estimated for median sensory latency values ranging from 3.3 to 4.1 
milliseconds, in 0.1-millisecond intervals, for each of the 2 symptom-based criteria while 
holding the reference values for motor latency at 4.5 milliseconds and the transcarpal delta 
latency at 0.8 millisecond. Similarly, median motor nerve latency values were varied from 
4.1 to 4.9 milliseconds, and transcarpal delta latency values were varied from 0.4 to 1.2 
milliseconds.
The CTS case definitions used symptoms (eg, numbness, tingling, burning, pain) in either 
≥1 or ≥2 digits innervated by the median nerve and the specific EDS criteria previously 
described. CTS prevalence was also calculated based on EDS criteria used in prior studies to 
allow for comparison.13–24
Results
Data from a total of 3130 participants were included in these pooled analyses. Demographic 
characteristics of the pooled sample are provided in table 1. Both sexes were well 
represented (women: n=1523, 48.7%), and the mean body mass index (28.5kg/m2) indicates 
that a large proportion of participants were overweight or obese. Approximately half 
(50.3%) were lifelong nonsmokers. Relatively few, 115 (3.7%) and 156 (5.0%), had 
physician-diagnosed diabetes mellitus or thyroid disorder, respectively.
The estimated prevalence of CTS for each of the 6 analyses is reported in figure 1 and 
ranged from 6.3% to 11.7%. As expected, the lowest cutpoint values for sensory latency, 
motor latency, and transcarpal delta each yielded the highest number of observed cases. 
Substantial differences in prevalence were observed as each cutpoint value was increased. 
The largest change in relative prevalence occurred when varying the sensory latency, 
whereas the smallest change in relative prevalence occurred when varying the motor latency. 
As expected, the observed CTS prevalence for symptoms in ≥1 digit was between 0.9% and 
2.0% higher than the prevalence requiring symptoms in ≥2 digits.
In addition, prior published criteria for EDS thresholds consistent with CTS were applied to 
the pooled data sample of the current study to calculate CTS prevalence (table 2). The 
prevalence rates ranged nearly 2-fold, from 5.9% to 11.6%, depending on the EDS criteria 
and symptom definition used (eg, ≥1 digit or ≥2 digits).
For reference purposes, the prevalence rates were also calculated using only 1 EDS measure 
instead of all 3 (eg, sensory, motor, transcarpal delta) (table 3). The prevalence rates are 
therefore lower than in figure 1.
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Discussion
These results suggest that varying the threshold of the median motor nerve latency or the 
transcarpal delta latency has less effect, per millisecond of change, on observed CTS 
prevalence than varying the threshold of the median sensory nerve latency. In this 
population of industrial workers, changes to the median sensory nerve latency criterion has 
more than 3-fold greater impact on the observed CTS prevalence than changes to either the 
median motor nerve latency or transcarpal delta latency. The effects of changing the 
cutpoints in this study were also not linear. The largest effects were observed over changes 
to the lower cutpoint values.
Although it is known qualitatively that changes in EDS cut-points will result in changes in 
the observed prevalence of CTS, our study findings quantify these effects across a range of 
values for 3 common EDS metrics in a large and representative sample. To our knowledge, 
these effects have not been quantified before. These results help to illuminate the extent to 
which the variability of CTS prevalence reported in the published literature may be solely 
attributed to differences in CTS case definition criteria.
The estimated prevalence of CTS decreased by between 0.9% and 2.0% when comparing the 
symptom criterion from paresthesias or pain in ≥1 digits with paresthesias or pain in ≥2 
digits, regardless of the EDS criteria used. Few studies evaluating CTS provide sufficient 
description of case definitions to allow for differentiation between symptoms in ≥1 and ≥2 
median nerve–served digits. Most published case definitions of CTS in peer-reviewed 
research rely on combinations of symptoms in ≥1 of multiple areas, including the fifth digit 
(not normally innervated by the median sensory nerve) and the hand and wrist.51–53
Analysis of a subset of data where sites reported pain or burning independently of numbness 
or tingling was performed to evaluate differences in estimated prevalence when including 
pain or burning as a symptom criteria. When using numbness or tingling in the median 
nerve–served digits alone, there was a reduction of prevalence by 11.5% to 8.7%. Of the 
prevalent cases in the subset analysis, 2.8% were symptomatic for pain or burning and did 
not report numbness or tingling in the median nerve–served digits. Therefore, these data 
suggest that when restricting the case definition to numbness or tingling symptoms, 
prevalence will decrease by approximately 25%.
A study of 1646 hands of 824 workers reported a prevalence of abnormal EDSs of 12.2% 
when applying a transcarpal delta value of 0.5 millisecond and 5.1% for a transcarpal delta 
value of 0.8 millisecond.54 When combined with any symptoms of the wrist, hands, or digits 
on 3 occasions over the last year, the prevalence for a transcarpal delta of 0.5 millisecond 
was reduced from 12.2% to 6.7%. A study of 1079 dentists used case definitions with a 
threshold for the transcarpal delta of 0.5 or 0.8 millisecond in combination with a median 
sensory latency >3.7 milliseconds and reported abnormal EDS prevalence of 13.0% and 
6.7%, respectively.55 When abnormal EDS findings were combined with any symptom in 
the hand or digits, the reported prevalence rates were 4.8% and 2.9%, respectively. These 
are lower prevalence values than observed in our study, likely because the subjects of our 
study performed hand-intensive work, were more obese, and were at a higher risk than 
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dentists for CTS. However, the difference in prevalence of 1.9% (4.8%–2.9%) between the 
transcarpal delta thresholds of 0.5 and 0.8 millisecond is similar to the differences of 1.9% 
(symptoms in ≥1 digit) and 1.8% (symptoms in ≥2 digits) observed in our study.
There were large differences in observed prevalence across the EDS criteria used in this 
study. The difference in prevalence, when varying the sensory latency from 3.3 to 4.1 
milliseconds, may have a substantial impact on researchers’ abilities to accurately 
differentiate relations within studies evaluating potential risk factors or treatments for CTS. 
Selection of EDS criteria with maximum specificity to accurately diagnose true cases while 
not sacrificing sensitivity is needed. Strict EDS criteria would lead to lower prevalence 
estimates but may yield more accurate measures of disease than if less stringent EDS criteria 
were used. Conversely, less stringent EDS criteria will increase case numbers and study 
power but may lead to more false-positive cases and case misclassification and therefore 
may result in erroneous conclusions. This difference may partially explain different findings 
in studies evaluating risk factors for CTS.2 There also exists the possibility of directional 
misclassification in either direction, dependent on the criteria and symptoms, therefore 
allowing for bias. Careful, a priori consideration of the appropriate cutpoints to use, which 
balance sensitivity and specificity, may have a meaningful impact on study findings.
Additionally, there are meaningful implications regarding prevalence measures of CTS. 
Differences in EDS criteria and the resulting prevalence may have a meaningful impact on 
the proportion of those with a positive test result who are truly positive (positive predictive 
value), the proportion of those with a negative test result who are truly negative (negative 
predictive value), and the number needed to treat. Other authors have hypothesized that 
there may be a meaningful difference in case counts depending on the EDS criteria used. 
Werner and Andary34 discuss the potential impact of varying EDS criteria. These data 
quantify these differences in a large population of workers and allow for more direct 
comparisons between prior published studies.
Much of the literature has focused on the discussion relating to transcarpal delta 
measurements for the removal of potential intrapersonal variation by using an internal 
comparison between the median and ulnar nerve. The abnormal classification threshold for 
this value has increased over time from 0.3 millisecond in the 1980s, to 0.4 and 0.5 
millisecond in the 1990s, to as high as 1.0 millisecond for patients who are mildly 
diabetic.18,21,25–33,56 Although the transcarpal delta is an important measure in the diagnosis 
of CTS, additional EDS measures have not received the same level of consideration in the 
literature. These data support further scrutiny of the sensory latency criterion, in addition to 
the transcarpal delta criterion, relating to clinical manifestation of symptoms in both ≥1 and 
≥2 median nerve–served digits.
Study limitations
Differences in symptomology between studies blur the potential relation between EDS 
criteria and the CTS case definition. Some studies include symptoms only in digits 1 through 
3, whereas others rely on digits 1 through 4. When restricting these data to digits 1 through 
3, there were no meaningful differences in trends (data not shown); however, prevalence 
measures were uniformly slightly lower. Differentiation between symptom criteria of digits 
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1 through 3 compared with digits 1 through 4 in future studies may further illustrate 
relations between EDS criteria and the CTS case definition.
Future research in this field will help to clarify the impacts of the CTS case definition on 
prevalence estimates in other populations and the impacts of these differences on CTS 
incidence. Although these data suggest that changing the cutpoint for motor latency or the 
transcarpal delta has relatively little effect on prevalence estimates, this may not be true in 
all populations and remains to be replicated. In these data there are multiple factors that have 
a relatively large impact on CTS prevalence estimates. These factors include the number of 
symptomatic digits and sensory latency cutpoint values used for CTS case definition. These 
differences are yet to be evaluated in incidence cases from prospective data.
Conclusions
There were meaningful differences in observed CTS prevalence in a pooled cohort of 
working individuals over a range of commonly used values to classify EDS as consistent 
with CTS. The effects on estimated CTS prevalence were greatest for the median sensory 
latency when compared with the median motor latency or trans-carpal delta. These results 
allow readers to quantify at least some of the variance observed in published studies of CTS 
prevalence.
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Fig. 1. 
Prevalence of CTS in a pooled working population when varying the EDS criteria of sensory 
latency, motor latency or transcarpal delta by 0.1 millisecond. The reference values for 
sensory were 3.7 milliseconds, motor 4.5 milliseconds, and transcarpal delta 0.8 millisecond.
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Table 1
Demographic data for the sample of 3061 participants
Characteristic Value
Age (y) 37.5±11.9
Female 1523 (48.7)
Body mass index (kg/m2) 28.5±6.3
Diabetes mellitus 115 (3.7)
Thyroid disorder 156 (5.0)
Smoking
 Current 956 (30.7)
 Past 601 (19.3)
 Never 1573 (50.3)
Median sensory latency (ms) 3.48±0.64
Median motor latency (ms) 3.86±0.75
Transcarpal delta (ms) 0.42±0.49
NOTE. Values are mean ± SD or n (%).
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Table 3
Prevalence of CTS based on individual EDS criterion applied to these pooled data
Latency No Symptoms Symptoms in ≥1 Digit Symptoms in ≥2 Digits
Sensory latency
 3.3ms 1365 (43.6) 364 (11.6) 302 (9.7)
 3.4ms 1153 (36.8) 332 (10.6) 280 (9.0)
 3.5ms 946 (30.2) 295 (9.4) 257 (8.2)
 3.6ms 787 (25.1) 275 (8.8) 240 (7.7)
 3.7ms 636 (20.3) 255 (8.2) 222 (7.1)
 3.8ms 525 (16.8) 217 (6.9) 195 (6.2)
 3.9ms 419 (13.4) 197 (6.3) 179 (5.7)
 4.0ms 349 (11.2) 182 (5.8) 167 (5.3)
 4.1ms 280 (9.0) 166 (5.3) 154 (4.9)
Motor latency
 4.1ms 714 (22.8) 219 (7.0) 188 (6.0)
 4.2ms 588 (18.8) 193 (6.2) 169 (5.4)
 4.3ms 515 (16.5) 183 (5.9) 162 (5.2)
 4.4ms 408 (13.0) 156 (5.0) 140 (4.5)
 4.5ms 344 (11.0) 140 (4.5) 125 (4.0)
 4.6ms 293 (9.4) 127 (4.1) 113 (3.6)
 4.7ms 261 (8.3) 116 (3.7) 106 (3.4)
 4.8ms 221 (7.1) 105 (3.4) 96 (3.1)
 4.9ms 176 (5.6) 92 (2.9) 84 (2.7)
Transcarpal delta
 0.4ms 761 (24.3) 265 (8.5) 229 (7.3)
 0.5ms 571 (18.2) 238 (7.6) 206 (6.6)
 0.6ms 468 (15.0) 210 (6.7) 181 (5.8)
 0.7ms 374 (12.0) 182 (5.8) 161 (5.1)
 0.8ms 302 (9.7) 171 (5.5) 151 (4.8)
 0.9ms 239 (7.6) 148 (4.7) 134 (4.3)
 1.0ms 205 (6.6) 128 (4.1) 117 (3.7)
 1.1ms 174 (5.6) 113 (3.6) 104 (3.3)
 1.2ms 147 (4.7) 99 (3.2) 91 (2.9)
NOTE. Values are n (%).
Arch Phys Med Rehabil. Author manuscript; available in PMC 2015 February 26.
